Given the high basal expression of caspase-4 in colon cancer cells and given that SSa induces colon cancer-specific apoptosis and triggers caspase-4 cleavage and activation, we hypothesized that altered expression of caspase-4 may be an underlying cause of the selective effects of SSa. The gene discussed is CASP4; the disease is malignant colon neoplasm.